Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.tracli.2021.02.005 http://scihub22266oqcxt.onion/10.1016/j.tracli.2021.02.005 33675992!7927574!33675992     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Transfus+Clin+Biol 2021 ; 28 (2): 132-134 Nephropedia Template TP {{tp|p=33675992|t=2021. Impact of pathogen-reduction technologies on COVID-19 convalescent plasma potency |pdf=|usr=}}{{33675992}} gab.com Text Impact of pathogen-reduction technologies on COVID-19 convalescent plasma potency JO: Transfus Clin Biol http://www.kidney.de/pget.php?&tw=1&pmid=33675992 #FOAvip Pathogen reduction technologies (PRT) have been recommended by many regulatory authorities to minimize the residual risk of transfusion-transmitted infections associated with COVID19 convalescent plasma. While its impact on safety and its cost-effectiveness are nowadays well proven, there is theoretical concern that PRT could impact efficacy of convalescent plasma by altering concentration and/or function of the neutralizing antibodies (nAb). We review here the evidence supporting a lack of significant detrimental effect from PRTs on nAbs. Twit Text FOAVip Impact of pathogen-reduction technologies on COVID-19 convalescent plasma potency ????Transfus Clin Biol http://www.kidney.de/pget.php?&tw=1&pmid=33675992 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33675992 #FOAvip English Wikipedia <ref>{{Cite pmid|33675992}}</ref> Impact of pathogen-reduction technologies on COVID-19 convalescent plasma potency #MMPMID33675992 Focosi D; Franchini M Transfus Clin Biol 2021[May]; 28 (2): 132-134 PMID33675992show ga Pathogen reduction technologies (PRT) have been recommended by many regulatory authorities to minimize the residual risk of transfusion-transmitted infections associated with COVID19 convalescent plasma. While its impact on safety and its cost-effectiveness are nowadays well proven, there is theoretical concern that PRT could impact efficacy of convalescent plasma by altering concentration and/or function of the neutralizing antibodies (nAb). We review here the evidence supporting a lack of significant detrimental effect from PRTs on nAbs. |Antibodies, Neutralizing/blood[MESH] |COVID-19 Serotherapy[MESH] |COVID-19/blood/*therapy[MESH] |Humans[MESH] |Immunization, Passive/adverse effects[MESH] |Infection Control/*methods[MESH] |Transfusion Reaction/*prevention & control[MESH]Impact of pathogen-reduction technologies on COVID-19 convalescent pla(epmc).pdf DeepDyve Pubget Overpricing